Validation and comparison of two solid-phase immunoassays for the quantification of S-100B in human blood

Clinical Chemistry

Volumn 46, Issue 7, 2000, Pages 993-996

  Missler, Ulrich ^a   Wiesmann, Martin ^a   Ehlermann, Philipp ^a   Tronnier, Michael ^a   Nötzold, Axel ^a   Steinmeier, Elke ^a   Wood, W Graham ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Municipal Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN S 100;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BRAIN INJURY; CONTROLLED STUDY; CROSS REACTION; FEMALE; HEART SURGERY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MELANOMA; PROTEIN ANALYSIS; VALIDATION PROCESS;

EID: 0033927833     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.7.993     Document Type: Article

References (19)

1. Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuronspecific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997;28:1956-60.
2. Abraha HD, Butterworth RJ, Bath PMW, Wassif WS, Garthwaite J, Sherwood RA. Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann Clin Biochem 1997;34:366-70.
3. Wiesmann M, Missler U, Hagenström H, Gottmann D. S-100 protein plasma levels after subarachnoid haemorrhage. Acta Neurochir (Wien) 1997;139:1155-60.
4. Westaby S, Johnsson P, Parry AJ, Blomqvist S, Solem JO, Alling C, et al. Serum S100 protein: a potential marker for cerebral events during cardiopulmonary bypass. Ann Thorac Surg 1996;61:88-92.
5. Taggart DP, Bhattacharya K, Meston N, Standing SJ, Kay JD, Pillai R, et al. Serum S-100 protein concentration after cardiac surgery: a randomized trial of arterial line filtration. Eur J Cardiothorac Surg 1997;11:645-9.
6. 2+ binding protein family. Biometals 1998;11:383-97.
7. Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965;19:739-44.
8. Persson L, Hårdemark HG, Gustafsson J, Rundström G, Mendel-Hartvig I, Esscher T, et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke 1987;18:911-8.
9. Usui A, Kato K, Murase M, Hotta T, Tanaka M, Takeuchi E, et al. Neural tissue-related proteins (NSE, GOa, 28-kDa calbindin-D, S100b and CK-BB) in serum and cerebrospinal fluid after cardiac arrest. J Neurol Sci 1994;123:134-9.
10. Zimmer DB, Cornwall EH, Landar A, Song W. The S100 protein family: history, function, and expression. Brain Res Bull 1995;37:417-29.
11. 2+ binding protein S100A1 from myocardium and recombinant E. coli. J Chromatogr B Biomed Sci Appl 2000;737:39-45.
12. Engelkamp D. Schäfer BW, Erne P, Heizmann CW. S100α, CAPL, CACY: molecular cloning and expression analysis or three calcium-binding proteins from human heart. Biochemistry 1992;31:10258-64.
13. Wiesmann M, Missler U, Gottmann D, Gehring S. Plasma S-100b protein concentration in healthy adults is age and sex independent. Clin Chem 1998;44:1056-8.
14. Wiesmann M, Wandinger KP, Missler U, Eckhoff D, Rothermundt M, Arolt V, et al. Elevated plasma levels of S-100b protein in schizophrenic patients. Biol Psychiatry 1999;45:1508-11.
15. Woertgen C, Rothoerl RD, Holzschuh M, Metz C, Brawanski A. Comparison of serial S-100 and NSE serum measurements after severe head injury. Acta Neurochir (Wien) 1997;139:1161-5.
16. Usui A, Kato K, Abe T, Murase M, Tanaka M, Takeuchi E. S-100ao protein in blood and urine during open-heart surgery. Clin Chem 1989;35:1942-4.
17. 2+ binding S100 proteins in normal human skin and melanocytic lesions. Br J Dermatol 1997;137:39-43.
18. Cho KH, Hashimoto K, Taniguchi Y, Pietruk T, Zarbo RJ, An T. Immunohistochemical study of melanocytic nevus and malignant melanoma with monoclonal antibodies against S-100 subunits. Cancer 1990;66:765-71.
19. Barger SW, Wolchok SR, van Eldik LJ. Disulfide-linked S100b dimers and signal transduction. Biochim Biophys Acta 1992;1160:105-12.